Bayer (BAYN GY) files a lawsuit against Johnson & Johnson (JNJ) and Janssen Biotech; Says J&J claims on NUBEQUA are deeply flawed and are intentionally aimed at boosting sales of ERLEADA, with Bayer seeking injunction and damages
Importance
Level 1
#GERMANY#EUROPE#JOHNSON & JOHNSON#JNJ.US#BAYER AG#BAYN.GY#EQUITIES#EU SESSION#US SESSION#PHARMACEUTICALS#PHARMACEUTICALS (GROUP)#PHARMACEUTICALS, BIOTECHNOLOGY & LIFE SCIENCES#BAYN#EURO STOXX 50#S&P 500 INDEX#DAX 40 INDEX#JNJ#GLOBAL EQUITIES